Skye Bioscience, Inc. (SKYE)

Skye Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	46.42	68.42	1.26	1.24	8.98	2.47
Short-Term Investments	12.8	-	-	0.07	-	-
Cash & Short-Term Investments	59.22	68.42	1.26	1.32	8.98	2.47
Cash Growth	-29.04%	5345.15%	-4.72%	-85.32%	263.77%	34.94%
Other Receivables	0.01	0.01	0.7	0.18	-	-
Receivables	0.01	0.01	0.7	0.18	-	-
Prepaid Expenses	0.58	0.2	0.19	0.78	0.57	0.19
Restricted Cash	-	-	9.08	0	0	0
Other Current Assets	3.21	2.2	0.42	6.66	0.06	0
Total Current Assets	63.03	70.83	11.65	8.94	9.61	2.66
Property, Plant & Equipment	1.71	1.88	0.28	0.16	0.23	0.01
Other Long-Term Assets	0.05	0.05	0.01	0.01	0.01	-
Total Assets	64.79	72.76	11.94	9.11	9.86	2.67
Accounts Payable	1.71	0.57	0.96	1.79	0.9	0.36
Accrued Expenses	1.5	1.77	2.06	1.12	0.9	0.32
Short-Term Debt	-	-	4.37	0.06	-	-
Current Portion of Long-Term Debt	-	-	-	1.85	1.97	0.06
Current Portion of Leases	0.19	0.18	0.07	0.08	0.08	-
Other Current Liabilities	1.91	1.82	6.44	7.22	0.06	0.04
Total Current Liabilities	5.32	4.34	13.9	12.12	3.91	0.79
Long-Term Debt	-	-	-	-	-	1.43
Long-Term Leases	0.22	0.27	0.17	-	0.08	-
Total Liabilities	5.54	4.61	14.07	12.12	3.99	2.22
Common Stock	0.03	0.03	0.01	0	0.48	0.29
Additional Paid-In Capital	201.27	199.07	102.24	63.73	52.64	38.9
Retained Earnings	-142.05	-130.95	-104.38	-66.74	-47.26	-38.73
Total Common Equity	59.25	68.15	-2.13	-3.01	5.86	0.45
Shareholders' Equity	59.25	68.15	-2.13	-3.01	5.86	0.45
Total Liabilities & Equity	64.79	72.76	11.94	9.11	9.86	2.67
Total Debt	0.41	0.46	4.62	1.98	2.14	1.5
Net Cash (Debt)	58.81	67.96	-3.36	-0.66	6.85	0.97
Net Cash Growth	-25.20%	-	-	-	604.71%	-32.66%
Net Cash Per Share	1.49	1.86	-0.48	-0.30	4.21	1.05
Filing Date Shares Outstanding	30.98	30.97	28.06	3.89	1.98	1.4
Total Common Shares Outstanding	30.97	30.97	12.35	3.65	1.9	1.15
Working Capital	57.71	66.49	-2.25	-3.18	5.7	1.88
Book Value Per Share	1.91	2.20	-0.17	-0.82	3.08	0.39
Tangible Book Value	59.25	68.15	-2.13	-3.01	5.86	0.45
Tangible Book Value Per Share	1.91	2.20	-0.17	-0.82	3.08	0.39
Machinery	-	1.64	0.12	-	-	-
Leasehold Improvements	-	0.02	0.01	-	-	-

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q